Medical Marijuana, Inc. CEO Covered by National Mexico Media Outlets Discussing Landmark Firsts, CBD Market at A4M Mexico

Wednesday, March 1, 2017 General News
Email Print This Page Comment
Font : A-A+

SAN DIEGO, Feb. 23, 2017 /PRNewswire/ -- Medical Marijuana, Inc. (OTC PINK: MJNA), the first publicly traded cannabis

company in the United States, Chief Executive Officer, Dr. Stuart Titus, recently participated in a much-anticipated A4M Mexico conference and was featured by national media outlets,
speaking about the Company's landmark achievements in Mexico and the future of the cannabidiol (CBD) industry.

Dr. Titus was a featured speaker at the A4M Mexico event where he discussed the CBD industry in Mexico. He discussed his hope that Mexico will continue to put forward more reforms that will allow CBD to be available to individuals suffering from multiple medical indications.

Additionally, Dr. Titus was recently featured in numerous top-tier Mexico media outlets like, were he discussed not only the growing market and the industry as a whole, but specific milestones Mexico has recently achieved in the industry. One such milestone is that Mexico's health authority, COFEPRIS, has given permission for HempMeds Mexico® to import RSHO-X to treat a patient for their pain associated with cancer treatments and for their general well-being.

"Ever since we were welcomed into Mexico in February 2016, we have been able to help over 260 children with refractory epilepsy challenges," Dr. Titus stated. "It was a great honor and privilege to speak at the A4M Mexico event as well as to the media outlets interested in helping to tell this amazing story and showcase the health and wellness benefits that CBD can bring to the people of Mexico."

Dr. Titus's Mexico visit and speech at the A4M Mexico conference were also covered by and

About Medical Marijuana, Inc.Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit

To see Medical Marijuana, Inc.'s video statement, click here. Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.

About HempMeds® MexicoHempMeds®Mexico is a Mexico-based company that made history by being the first company to receive a COFEPRIS federal government import permit for the cannabis product RSHO-X™ for a medical indication. HempMeds® Mexico plans to work directly with the Mexican government to safely and legally provide access to CBD hemp oil products. For more information, please review the company's website at:

FORWARD-LOOKING DISCLAIMER AND DISCLOSURESThis press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties. The statements in this press release have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.  The Company does not sell or distribute any products that are in violation of the United States Controlled Substances Act. The Company does sell and distribute hemp-based products.

CONTACT:Public Relations Contact:Andrew HardChief Executive OfficerCMW MediaP. 888-829-


To view the original version on PR Newswire, visit:

SOURCE Medical Marijuana, Inc.

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store